new IV bisphosphonate called Zometa (zoledronic acid)

Novartis will soon market a new IV bisphosphonate called Zometa (zoledronic acid).

It will be used as an alternative to Aredia (pamidronate)... for hypercalcemia and bone metastases in cancer patients.

Bisphosphonates help lower serum calcium by inhibiting bone resorption. They also reduce bone pain and fractures in patients with bone metastases.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: PA includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote